In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
ACCA Clinical Decision Making Toolkit

One of the best tools to help practitioners make the best bedside clinical decisions when managing patients with acute cardiovascular diseases.

See more
Be Guidelines Smart

A comprehensive guidelines implementation toolkit especially for Nurses & Allied Professionals. 

See more
Prevention Toolbox

Practical decision-making tools designed to support health professionals and policy makers in their daily practice: HeartScore, HeartQoL and more.

See more

About the programme



Secondary prevention - the facts

  • Cardiovascular Disease (CVD) is the world’s number one killer, accounting for 1 in 5 deaths in Europe

  • Without effective treatment of risk and risk factors, the immediate mortality after an acute event increases with a further rise in patients dying in the subsequent year

  • In those who survive an initial post-MI period, an increased risk of death from cardiovascular causes persists indefinitely

  • Reducing morbidity and mortality among post-myocardial infarction and other patients at high risk of subsequent event require the implementation of effective prevention measures

  • Evidence shows an increase in risk factor awareness in developing countries, but a decrease in developing countries – this issue is a global problem

  • Guidelines targets are achievable: Evidence shows that effective secondary prevention measures outlined in clinical practice Guidelines can significantly reduce the risk of a subsequent cardiovascular event

  • There is a need and room for improvement!

About the ESC Prevention of CVD Programme 

The ESC Prevention of CVD Programme is led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). The programme is being rolled out in three phases:

  • Phase I: Secondary Prevention after Myocardial Infarction (completed)
    Understanding the needs - Evaluating gaps in knowledge & adherence to treatment: literature review, health professional survey and awareness initiative.
  • Phase II: Focus on Secondary Prevention (January 2016 - June 2017)
    Development of educational programme and tools for improved management of high risk patients and patients after acute coronary syndromes: scientific resources, educational activities and practical tools. 
  • Phase III: Continued Roll-out, Evaluation and Follow-up

The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer, and Sanofi and Regeneron in the form of educational grants.